Close Menu

NEW YORK – Enpicom and Viroclinics-DDL said Tuesday that they have received an MIT-Zuid subsidy worth an undisclosed amount to accelerate a partnership to discover and develop antibodies and vaccines.

The funding, from a program to support innovation in the Dutch province of South Holland, will help the companies expand an existing two-year-old collaboration to provide T-cell receptor repertoire sequencing and analysis services to groups researching diseases of the immune system and potential therapies for these ailments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.